1. News | 06.12.26

    Arcadia Biosciences Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

    DALLAS, Texas (June 12, 2026) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred…Continue Reading »
  2. News | 06.11.26

    Arcadia Biosciences Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

    DALLAS, Texas (June 11, 2026) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up…Continue Reading »
  4. News | 03.26.26

    Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights

    — Zola® revenues increase 17% year-over-year — — Arcadia and Roosevelt Resources terminate proposed business combination — — Exercise of preferred investment options yields $2.1 million gross proceeds —  DALLAS, Texas (March 26, 2026) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results…Continue Reading »
  5. News | 01.12.26

    Arcadia Biosciences Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds

    DALLAS, Texas (January 12, 2026) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that it has entered into definitive agreements for the immediate exercise of certain outstanding preferred investment options to purchase up to an aggregate of 808,595 shares originally issued in December 2020, January 2021, August…Continue Reading »
  6. News | 12.26.25

    Arcadia Biosciences Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

    DALLAS, Texas (December 26, 2025) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that on December 24, 2025, it received a notice from Roosevelt Resources, LP, terminating the Securities Exchange Agreement between Arcadia and Roosevelt dated December 4, 2024, pursuant to the terms of the agreement. The…Continue Reading »